In this video, Gus Alva, MD, Medical Director, ATP Clinical Research, Costa Mesa, California, discusses the recent FDA-approved long-acting injectable (LAI) paliperidone palmitate administered twice a year, for the treatment of schizophrenia....
In this video, Gus Alva, MD, Medical Director, ATP Clinical Research, Costa Mesa, California, discusses the recent FDA-approved long-acting injectable (LAI) paliperidone palmitate administered twice a year, for the treatment of schizophrenia....
In this video, Gus Alva, MD,...